Daptomycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 72603-152

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Daptomycin (NDC 72603-152). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton-label (Carton Label)

Packaging label for Daptomycin for Injection, 500 mg per vial, lyophilized powder for intravenous injection. The label states that it must be refrigerated and used with 0.9% Sodium Chloride Injection for reconstitution. Manufactured by NorthStar Rx LLC and ASPRIO Pharma Limited. The label includes storage instructions and a barcode.*

FDA Label Image

Daptomycinestructure (Daptomycinestructure)

Chemical structure diagram of Daptomycin showing its molecular framework with various rings, side chains, and functional groups characteristic to this antibiotic compound.*

FDA Label Image

Vial-label (Vial Label)

Label for Daptomycin for Injection 500 mg per vial, lyophilized powder for intravenous injection. The label specifies it must be refrigerated and reconstituted with 10 mL 0.9% Sodium Chloride Injection. It includes storage instructions and manufacturer information for NorthStar Rx LLC and Aspiro Pharma Limited, India, with barcode and lot/expiration placeholders.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.